Opiant Pharmaceuticals, Inc. announced the Compensation and Human Capital Committee of the Company’s Board of Directors has approved the grant of restricted stock units covering an aggregate of 25,900 shares of common stock to seven hired employees, pursuant to the Company’s 2022 Inducement Equity Incentive Plan.
June 28, 2022
· 2 min read